| Cvs Pharmacy #09306 | |
| 19505 N Sunrise Blvd, Surprise, Arizona 85374 | |
| (623) 556-4778 |
| Name | Cvs Pharmacy #09306 |
|---|---|
| Organization Name | Arizona Cvs Stores Llc |
| Location | 19505 N Sunrise Blvd, Surprise, Arizona 85374 |
| Type | Pharmacy |
| Phone | (623) 556-4778 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.
Genkyotex, the leading developer of selective NOX enzyme inhibitors, announced today the publication of data showing that GKT137831, a first in class NOX1 and 4 inhibitor, was able to reverse lung fibrosis associated with aging in a new model of idiopathic pulmonary fibrosis.
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
› Verified 3 days ago
| NPI Number | 1285675223 |
| Organization Name | ARIZONA CVS STORES LLC |
| Doing Business As | CVS PHARMACY 09306 |
| Type | Pharmacy |
| Address | 19505 N Sunrise Blvd, Surprise, AZ 85374 |
| Phone Number | 623-556-4778 |
News Archive
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.
Genkyotex, the leading developer of selective NOX enzyme inhibitors, announced today the publication of data showing that GKT137831, a first in class NOX1 and 4 inhibitor, was able to reverse lung fibrosis associated with aging in a new model of idiopathic pulmonary fibrosis.
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
› Verified 3 days ago
News Archive
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.
Genkyotex, the leading developer of selective NOX enzyme inhibitors, announced today the publication of data showing that GKT137831, a first in class NOX1 and 4 inhibitor, was able to reverse lung fibrosis associated with aging in a new model of idiopathic pulmonary fibrosis.
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
› Verified 3 days ago
Cvs Pharmacy # 01743 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 13870 W Greenway Rd, Surprise, Arizona 85374 Phone: (623) 546-0512 | |
Cvs Pharmacy #05477 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15474 W Greenway Rd, Surprise, Arizona 85374 Phone: (623) 584-1964 | |
Cvs Pharmacy #05530 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15300 N Cotton Lane, Surprise, Arizona 85388 Phone: (623) 584-8558 | |
Cvs Pharmacy #09306 Type: Pharmacy Location: 19505 N Sunrise Blvd, Surprise, Arizona 85374 Phone: (623) 556-4778 | |
German Dobson Cvs Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 13731 E Bell Rd, Surprise, Arizona 85374 Phone: (623) 975-4379 |